Its mechanisms of action target key inflammatory pathways involved in atherosclerosis, particularly through inhibition of neutrophil activation, NLRP3 inflammasome assembly, and modulation of endothelial dysfunction. This evidence concerns the gene NLRP3 and atherosclerosis.